2024-09-24 - Analysis Report
## Thermo Fisher Scientific Inc (TMO) Stock Analysis

**Company Overview:** Thermo Fisher Scientific Inc is a leading provider of scientific instruments, reagents, and consumables for the life sciences, pharmaceutical, and industrial markets.

**1. Performance vs S&P 500 (VOO):**

* **Cumulative Return:** TMO (251.8) vs VOO (132.53)
* **Performance Difference:** TMO has outperformed VOO by 119.27 points.
* **Relative Divergence:** TMO currently sits at 54.98% relative to the historical range of performance difference (max: 216.12, min: -3.86). This indicates that TMO's performance is relatively strong compared to VOO, though not at its peak.

**2. Recent Price Action:**

* **Closing Price:** $613.69
* **5-day Moving Average:** $613.65
* **20-day Moving Average:** $612.76
* **60-day Moving Average:** $588.57

The stock price is currently trading above all moving averages, suggesting an upward trend. The 5-day moving average is close to the closing price, indicating short-term stability.

**3. Technical Indicators:**

* **RSI:** 49.04
* **PPO:** -0.18
* **Delta_Previous_Relative_Divergence:** -0.27 (Short-term decline)
* **Expected Return:** 99.13% (5-year expected return on invested capital)

The RSI indicates that the stock is neither overbought nor oversold, suggesting a neutral sentiment. The PPO is slightly negative, pointing towards a possible downward trend. The negative Delta_Previous_Relative_Divergence indicates a recent short-term decline. The high Expected Return suggests potential growth in the long term.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-08-02 | 4.05 | 10.54 B$ |
| 2024-05-03 | 3.47 | 10.35 B$ |
| 2023-11-03 | 4.44 | 10.57 B$ |
| 2023-08-04 | 3.53 | 10.69 B$ |
| 2024-08-02 | 3.53 | 10.69 B$ |

The most recent earnings were reported on 2024-08-02. While the company surpassed analyst estimates for revenue, it missed expectations for earnings per share. Despite this, the company's revenue continues to grow steadily, and its strong market position suggests continued growth potential.

**5. Overall Analysis:**

TMO has demonstrated consistent outperformance compared to the broader market, reflected in its strong cumulative return and high expected return. While recent technical indicators suggest a possible short-term decline, the company's strong fundamentals and growth potential make it a promising long-term investment. The recent earnings report, while missing EPS expectations, still shows continued revenue growth.

**6. Conclusion:**

TMO is a strong performer with a solid track record of growth. Despite recent short-term weakness, its long-term prospects remain positive. Investors looking for a long-term growth stock with a solid track record should consider adding TMO to their portfolios.
